RE: Lanstead ----The ball6 Apr 2020 10:04
From today's rns: Questions can be submitted pre-event at investors@immupharma.com or in real time during the presentation, via the "Ask a Question" function.
Noluplus, I suggest you use the above facility, you've raised some valid points imo. Seems the company wants to address general shareholder concerns. Am pleased to note this.